Deerfield Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-643,110
Closed -$5.87M 574
2024
Q1
$5.87M Hold
643,110
0.1% 72
2023
Q4
$1.77M Sell
643,110
-610,785
-49% -$1.42M 0.03% 63
2023
Q3
$4.56M Hold
1,253,895
0.1% 68
2023
Q2
$7.47M Sell
1,253,895
-479,199
-28% -$3.79M 0.16% 75
2023
Q1
$20.9M Buy
1,733,094
+1,428,571
+469% +$19M 0.47% 51
2022
Q4
$2.65M Sell
304,523
-209,825
-41% -$4.62M 0.05% 82
2022
Q3
$14.9M Sell
514,348
-56,818
-10% -$2.6M 0.3% 73
2022
Q2
$23.7M Buy
571,166
+151,515
+36% +$10.3M 0.49% 55
2022
Q1
$42.5M Sell
419,651
-3,586
-0.8% -$399K 0.95% 34
2021
Q4
$62.3M Buy
423,237
+3,586
+0.9% +$801K 1.31% 24
2021
Q3
$105M Buy
+419,651
New +$144M 2.05% 13

Other funds holding WGS

Deerfield Management's WGS Position: Q2 2024 in Review

Deerfield Management sold out of GeneDx Holdings (WGS) in Q2 2024, closing a stake of 643,110 shares — an estimated $5.87M sold.

Deerfield Management first reported a position in WGS in Q3 2021 and held it in 11 quarters. The position peaked at $105M in Q3 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q2 2024.

  • Deerfield Management reported no remaining GeneDx Holdings position as of Q2 2024 after selling out during the quarter.
  • Deerfield Management sold 643,110 GeneDx Holdings shares in Q2 2024, an estimated $5.87M.
  • Deerfield Management first reported a position in GeneDx Holdings in Q3 2021 and held it in 11 quarters.
  • Deerfield Management's GeneDx Holdings position peaked at $105M in Q3 2021.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.